{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:52Z","timestamp":1791308452740,"version":"4.3.1"},"reference-count":47,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,16]]},"DOI":"10.14797\/mdcvj.1230","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:09:26Z","timestamp":1684231766000},"page":"4-14","source":"Crossref","is-referenced-by-count":29,"title":["What\u2019s New with TAVR? An Update on Device Technology"],"prefix":"10.14797","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9426-3618","authenticated-orcid":false,"given":"Syed","family":"Zaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6619-5806","authenticated-orcid":false,"given":"Marvin D.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-8133","authenticated-orcid":false,"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-6132","authenticated-orcid":false,"given":"Michael J.","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7219-990X","authenticated-orcid":false,"given":"Gilbert H. L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"4","key":"key20230516100635_B1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jacc.2003.11.026","article-title":"Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis","volume":"43","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"key20230516100635_B2","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","article-title":"Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"key20230516100635_B3","first-page":"e35","article-title":"ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","year":"2020","journal-title":"Circulation"},{"issue":"21","key":"key20230516100635_B4","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement","volume":"76","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"28","key":"key20230516100635_B5","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehy244","article-title":"Transcatheter aortic valve implantation: current status and future perspectives","volume":"39","year":"2018","journal-title":"Eur Heart J"},{"key":"key20230516100635_B6","first-page":"U90","article-title":"New-generation TAVI devices: description and specifications","volume":"10 Suppl U","year":"2014","journal-title":"EuroIntervention"},{"issue":"Y","key":"key20230516100635_B7","doi-asserted-by":"crossref","first-page":"Y22","DOI":"10.4244\/EIJV12SYA6","article-title":"TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery","volume":"12","year":"2016","journal-title":"EuroIntervention"},{"issue":"9","key":"key20230516100635_B8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.cjca.2017.03.012","article-title":"Latest-Generation Transcatheter Aortic Valve Replacement Devices and Procedures","volume":"33","year":"2017","journal-title":"Can J Cardiol"},{"key":"key20230516100635_B9","article-title":"One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry","year":"2023","journal-title":"EuroIntervention"},{"issue":"9","key":"key20230516100635_B10","article-title":"Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve: A Propensity-Matched Analysis From the United States","volume":"14","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"key20230516100635_B11","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve; 2022 Dec 12 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05172960"},{"issue":"16","key":"key20230516100635_B12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jcin.2018.03.018","article-title":"\u201cCusp-Overlap\u201d View Simplifies Fluoroscopy-Guided Implantation of Self-Expanding Valve in Transcatheter Aortic Valve Replacement","volume":"11","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"key20230516100635_B13","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.amjcard.2020.01.008","article-title":"Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation","volume":"125","year":"2020","journal-title":"Am J Cardiol"},{"key":"key20230516100635_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2022.11.026","article-title":"Permanent Pacemaker Insertion Reduction and Optimized Temporary Pacemaker Management After Contemporary Transcatheter Aortic Valve Implantation With Self-Expanding Valves (from the Pristine TAVI Study)","volume":"189","year":"2023","journal-title":"Am J Cardiol"},{"issue":"6","key":"key20230516100635_B15","article-title":"Transcatheter Aortic Valve Replacement with the Self-Expandable Core Valve Evolut Prosthesis Using the Cusp-Overlap vs. Tricusp-View","volume":"11","year":"2022","journal-title":"J Clin Med"},{"key":"key20230516100635_B16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.carrev.2022.10.004","article-title":"Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk Trial","volume":"47","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"issue":"4","key":"key20230516100635_B17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jcin.2022.10.041","article-title":"Improved Commissural Alignment in TAVR With the Newest Evolut FX Self-Expanding Supra-Annular Valve: First-in-Human Experience","volume":"16","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"key20230516100635_B18","volume-title":"PCR London Valves Annual Meeting","year":"2022"},{"key":"key20230516100635_B19","article-title":"Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study","year":"2023","journal-title":"EuroIntervention"},{"key":"key20230516100635_B20","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation (VANTAGE); 2023 Jan 9 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04788888"},{"issue":"10209","key":"key20230516100635_B21","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S0140-6736(19)32220-2","article-title":"Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"25","key":"key20230516100635_B22","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.120.051547","article-title":"Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis: SCOPE 2 Randomized Clinical Trial","volume":"142","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"key20230516100635_B23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jcin.2022.02.027","article-title":"Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes","volume":"15","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"key20230516100635_B24","unstructured":"Ruck A. Results from the Early neo2 Registry Acurate neo2 TAVI Valve. Congress for the European Association of Percutaneous Cardiovascular Interventions (EuroPCR); 2021 May 18-20; Paris, France. Available from: https:\/\/media.pcronline.com\/diapos\/EuroPCR2021\/3890-20210518_0922_Clinical_Science_Ruck_Andreas_0000_(7805)\/Ruck_Andreas_20211805_1408_VOD.pdf"},{"key":"key20230516100635_B25","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement; 2023 Mar 30 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03735667"},{"issue":"22","key":"key20230516100635_B26","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","article-title":"Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation","volume":"70","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"key20230516100635_B27","first-page":"761","article-title":"A new self-expanding transcatheter aortic valve for transapical implantation - first in man implantation of the JenaValve\u2122","volume":"40","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"key20230516100635_B28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12471-014-0619-8","article-title":"\u201cFirst experience with JenaValve\u2122: a single-centre cohort\u201d","volume":"23","year":"2015","journal-title":"Neth Heart J"},{"issue":"11","key":"key20230516100635_B29","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4244\/EIJ-D-17-00502","article-title":"First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation","volume":"13","year":"2017","journal-title":"EuroIntervention"},{"key":"key20230516100635_B30","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study; 2022 Nov 18 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02732704"},{"key":"key20230516100635_B31","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study; 2022 Nov 22 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02732691"},{"issue":"18","key":"key20230516100635_B32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0735-1097(21)02278-6","article-title":"30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS","volume":"77","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20230516100635_B33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.hlc.2019.09.013","article-title":"Patient Risk Factors for Bioprosthetic Aortic Valve Degeneration: A Systematic Review and Meta-Analysis","volume":"29","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"6","key":"key20230516100635_B34","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrcardio.2016.43","article-title":"Durability of prostheses for transcatheter aortic valve implantation","volume":"13","year":"2016","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"key20230516100635_B35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jcin.2022.02.014","article-title":"5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses","volume":"15","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"key20230516100635_B36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves","volume":"312","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"key20230516100635_B37","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.athoracsur.2004.06.033","article-title":"Calcification of tissue heart valve substitutes: progress toward understanding and prevention","volume":"79","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"key20230516100635_B38","article-title":"Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement with RESILIA Tissue","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"key20230516100635_B39","first-page":"792","article-title":"Flat or curved pericardial aortic valve cusps: a finite element study","volume":"13","year":"2004","journal-title":"J Heart Valve Dis"},{"issue":"6","key":"key20230516100635_B40","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1016\/j.jtcvs.2014.08.002","article-title":"New engineering treatment of bovine pericardium confers outstanding resistance to calcification in mitral and pulmonary implantations in a juvenile sheep model","volume":"148","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key20230516100635_B41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fped.2020.00198","article-title":"Performance of the ADAPT-Treated CardioCel\u00ae Scaffold in Pediatric Patients With Congenital Cardiac Anomalies: Medium to Long-Term Outcomes","volume":"8","year":"2020","journal-title":"Front Pediatr"},{"issue":"12","key":"key20230516100635_B42","doi-asserted-by":"crossref","first-page":"B190","DOI":"10.1016\/j.jacc.2022.08.556","article-title":"TCT-471 First-in-Human Study Results With the Novel Anteris DurAVRTM Three-Dimensional Single-Piece TAVR Device","volume":"80","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"key20230516100635_B43","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. Use of DurAVR\u2122 THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study (DurAVR\u2122 EFS); 2023 Mar 10 [cited 2023 Apr 20]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT05712161"},{"key":"key20230516100635_B44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biomaterials.2014.09.013","article-title":"Polymeric heart valves for surgical implantation, catheter-based technologies and heart assist devices","volume":"36","year":"2015","journal-title":"Biomaterials"},{"issue":"24","key":"key20230516100635_B45","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1016\/j.jcin.2021.08.071","article-title":"Preliminary Evaluation of a Novel Polymeric Valve Following Surgical Implantation for Symptomatic Aortic Valve Disease","volume":"14","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"key20230516100635_B46","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2023. Early Feasibility Study for the Foldax Tria Aortic Heart Valve; 2022 Feb 25 [cited 2023 Apr 20]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03851068"},{"key":"key20230516100635_B47","unstructured":"Isrctn.com [Internet]. London, UK: Springer Nature; c2023. The role of cerebral embolic protection in preventing strokes and improving other health outcomes in patients receiving a replacement heart valve; 2022 Nov 11 [cited 2023 Apr 20]. Available from: https:\/\/www.isrctn.com\/ISRCTN16665769"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T10:10:02Z","timestamp":1684231802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1230\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5,16]]}},"alternative-id":["10.14797\/mdcvj.1230"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1230","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}